COVID-19 vaccination in France

Last updated

French vaccination campaign against COVID-19
Vaccination France COVID-19.svg
Date27 December 2020 (2020-12-27) – present
LocationFrance
Cause COVID-19 pandemic
TargetFull immunisation of people in France against COVID-19
Participants51,431,090 people have received at least one vaccine dose
50,312,831 people have been fully vaccinated
Outcome76.6% of the French population have received at least one vaccine dose
75.0% of the French population have been fully vaccinated
Website solidarites-sante.gouv.fr/grands-dossiers/vaccin-covid-19/
Pfizer vaccines ready to be injected in a vaccination center on 8 January 2021 in Strasbourg. Vaccins Covid-19 Hopitaux universitaires de Strasbourg 8 janvier 2021.jpg
Pfizer vaccines ready to be injected in a vaccination center on 8 January 2021 in Strasbourg.

COVID-19 vaccination in France started on 27 December 2020 after the approval of Pfizer/BioNTech vaccine by the European Union commission.

Contents

Vaccines on order

There are several COVID-19 vaccines at various stages of development around the world.

VaccineApprovalDeployment
Pfizer–BioNTech Green check.svg 21 December 2020Green check.svg 27 December 2020
Moderna Green check.svg 6 January 2021Green check.svg 12 January 2021
Oxford–AstraZeneca Green check.svg 29 January 2021Green check.svg 6 February 2021
Janssen Green check.svg 11 March 2021Green check.svg 23 April 2021
CureVac PendingDark Red x.svg Not yet
Novavax PendingDark Red x.svg Not yet
Valneva PendingDark Red x.svg Not yet
Sanofi–GSK PendingDark Red x.svg Not yet

Vaccines in trial stage

VaccineType (technology)Phase IPhase IIPhase III
VLA2001 InactivatedGreen check.svg CompletedGreen check.svg CompletedIn progress
CoVepiTSubunitIn progressDark Red x.svg Not yetDark Red x.svg Not yet
TMV-083Viral vector

Vaccination strategy

The vaccination strategy put in place by the government has three principal objectives: [1]

  1. Reduce mortality and severe forms of the disease
  2. Protect caregivers and the healthcare system
  3. Ensure vaccine and immunization safety

The vaccine is planned to be distributed in five phases.

Phase 1

Vaccination of a health worker at the Strasbourg University Hospital on 8 January 2021. Vaccination Covid 19 Hopitaux universitaires de Strasbourg 8 janvier 2021.jpg
Vaccination of a health worker at the Strasbourg University Hospital on 8 January 2021.

The first phase of vaccination concerns the highest priority audiences. Since 27 December 2020, it initially concerned nursing home and ESMS residents and staff over the age of 50. Vaccination has been open to caregivers over 50 since 2 January 2021, then to firefighters and domestic caregivers over 50 since 5 January 2021.

Phase 2

Vaccination of people aged over 75 in Strasbourg on 18 January 2021. Campagne de vaccination Covid19 Strasbourg 18 janvier 2021.jpg
Vaccination of people aged over 75 in Strasbourg on 18 January 2021.

This phase concerns people at high risk. From 18 January 2021, people aged 75 and over who do not reside in ESMS or nursing homes can be vaccinated. This phase will last until the end of February and concerns 5 million people. From the end of February, the vaccination will be open to people aged 65 to 74.

Phase 3

This phase concerns people who are more vulnerable than the general population. It will take place in the spring and include the following people.

Despite official priorities, any person older than 18 May be vaccinated in Bastia since 30 April 2021
Photo taken on 2 May 2021 Bastia-2-5-2020.jpg
Despite official priorities, any person older than 18 May be vaccinated in Bastia since 30 April 2021
Photo taken on 2 May 2021

Phase 4 and 5

Phases 4 and 5 will allow vaccination to be widely opened to those over 18.

Progress to date

Daily updates are provided by Santé Publique France. [3]


Vaccine deliveries

The following table details the weekly number of authorized vaccines delivered to France since the start of the crisis. [4] Among the suppliers, AstraZeneca is by far the most late compared to its initial commitments. In the 1st quarter of 2021, AstraZeneca is expected to deliver 30 million doses to the European Union, while the initial forecast was 120 million. [5] [6]


See also

Related Research Articles

Oxford–AstraZeneca COVID-19 vaccine Viral vector vaccine for prevention of COVID-19 by Oxford University and AstraZeneca

The Oxford–AstraZeneca COVID-19 vaccine, codenamed AZD1222, and sold under the brand names Covishield and Vaxzevria among others, is a viral vector vaccine for prevention of COVID-19. Developed in the United Kingdom by the Oxford University and British-Swedish company AstraZeneca, using as a vector the modified chimpanzee adenovirus ChAdOx1. The vaccine is given by intramuscular injection. Studies carried out in 2020 showed that the efficacy of the vaccine is 76.0% at preventing symptomatic COVID-19 beginning at 22 days following the first dose and 81.3% after the second dose. A study in Scotland found that, for symptomatic COVID-19 infection after the second dose, the vaccine is 81% effective against the Alpha variant, and 61% against the Delta variant.

COVID-19 vaccination in Sweden

Vaccination against COVID-19 in Sweden started on 27 December 2020 after the approval of the Pfizer–BioNTech vaccine by the European Commission. In Sweden, the Public Health Agency has been commissioned by the government to create a vaccination plan. Sveriges riksbank, the central bank of Sweden, predicts that efficient vaccination against COVID-19 has macroeconomic benefits. As of 1 September 2021, 82.0% of adults in Sweden have received at least one dose, with a total of 12,700,896 administered.

COVID-19 vaccination in Italy Immunization plan against COVID-19 in Italy

The COVID-19 vaccination campaign in Italy is a mass immunization campaign that was put in place by the Italian government in order to respond to the ongoing COVID-19 pandemic. It started on 27 December 2020, together with most countries in the European Union.

COVID-19 vaccination in Australia Ongoing COVID-19 vaccine program in Australia

The general COVID-19 vaccination in Australia program began on 22 February 2021 in response to the COVID-19 pandemic, and will continue with the goal of vaccinating all willing Australians before 2022. Front-line workers and aged care staff and residents will be the first Australians to be inoculated, before a gradual phased release to less-vulnerable and lower-risk population groups throughout 2021. The Therapeutic Goods Administration (TGA) approved four vaccines for Australian use in 2021: the Pfizer–BioNTech vaccine on 25 January, the Oxford–AstraZeneca vaccine on 16 February, Janssen vaccine on 25 June and the Moderna vaccine on 9 August. Although approved for use, the Janssen vaccine is not included in the Australian vaccination program.

COVID-19 vaccination in Romania started on 27 December 2020. It was announced that the process would be divided into three phases. Medical personnel would be vaccinated first, followed by the population at risk, and finally by the rest of the population. Vaccination was declared free and non-mandatory. As of May 2021, four types of vaccines were authorized to be used in Romania. This is the largest vaccination campaign in the modern history of Romania.

The following is a timeline of the COVID-19 pandemic in the province of Quebec.

COVID-19 vaccination in the Republic of Ireland Immunisation plan against COVID-19

The COVID-19 vaccination programme in the Republic of Ireland is an ongoing mass immunisation campaign that began on 29 December 2020 in response to the COVID-19 pandemic in the Republic of Ireland. Ireland's vaccination rollout has been praised as one of the most successful rollouts in the world and was ranked number one in the European Union in terms of its percentage of adult population fully vaccinated.

COVID-19 vaccination in Canada COVID-19 vaccination programme in Canada

The COVID-19 vaccination program in Canada is an ongoing, intergovernmental effort coordinated between the bodies responsible in the Government of Canada to acquire and distribute vaccines to individual provincial and territorial governments who in turn administer authorized COVID-19 vaccines during the COVID-19 pandemic in Canada. Some provinces have asked local municipal governments, hospital systems, family doctors and independently owned pharmacies to aid in part, or in full with vaccination rollout. The vaccination effort in full is the largest such immunization effort in the nation's history; it started in mid-December 2020 and is currently ongoing.

During the COVID-19 pandemic, Romania has supported Moldova on several occasions, supplying it with medical equipment and supplies, volunteer Romanian experts and doctors and even a series of COVID-19 vaccine units that arrived on 27 February 2021, which allowed Moldova to start its vaccination program.

COVID-19 vaccination in Moldova started on 2 March 2021. During the COVID-19 pandemic, Moldova was very reliant on external help from other countries, having received donations of vaccines from Romania, the United Arab Emirates, Russia and China. In fact, Moldova's vaccination campaign started due to a donation from Romania on 27 February 2021 composed of 21,600 Oxford–AstraZeneca COVID-19 vaccine doses, with the first vaccinated person in the country being Alexandru Botizatu. Romania had promised earlier, on 29 December 2020, that it would help Moldova with a collaboration project which would include 200,000 vaccine doses to help Moldova combat the pandemic, but also other matters of the country. Romania subsequently made more donations on 27 March 2021 with 50,400 vaccine units; on 17 April 2021 with 132,000 vaccine doses, fulfilling its promise to Moldova; and on 7 May 2021 with 100,800 vaccine units even though this surpassed the promised 200,000 vaccine doses.

COVID-19 vaccination in Botswana is an ongoing immunisation campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination program in Colombia is an ongoing effort of mass immunization put in place by the Colombian government in order to respond to the ongoing COVID-19 pandemic. The COVID-19 virus was confirmed to have reached Colombia on 6 March 2020. Colombia's preparation and readiness for a vaccine program allowed it to join the first group of countries who received vaccines through COVAX. The first vaccine in Colombia was given to a nurse on 17 February 2021.

COVID-19 vaccination in Africa Immunisation programme against COVID-19 in Africa

COVID-19 vaccination programs have begun in many countries and territories in Africa. As of 5 July 2021, vaccination campaigns had started in 51 African countries with 36.5 million people receiving at least one dose.

COVID-19 vaccination in Bhutan

Bhutan has promised a free COVID-19 vaccination to all of its citizens, both inside and outside the country. It started mass vaccinations on 27 March 2021.

Embolic and thrombotic events after COVID-19 vaccination Post vaccination adverse effects

Post-vaccination embolic and thrombotic events, also termed vaccine-induced prothrombotic immune thrombocytopenia (VIPIT), vaccine-induced immune thrombotic thrombocytopenia (VITT), or thrombosis with thrombocytopenia syndrome (TTS) are rare types of blood clotting syndromes that were initially observed in a number of people who had previously received the Oxford–AstraZeneca COVID-19 vaccine (AZD1222) during the COVID-19 pandemic. It was subsequently also described in the Janssen COVID-19 vaccine leading to suspension of its use until its safety had been reassessed.

COVID-19 vaccination in Mexico Plan to immunize against COVID-19

COVID-19 vaccination in Mexico is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country.

The COVID-19 vaccination campaign in Quebec is an ongoing provincial effort to distribute and administer the vaccine against COVID-19.

COVID-19 vaccination in Nigeria Plan to immunize against COVID-19

COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021. As of 8 October 2021, 5,118,422 people have received their first dose a COVID-19 vaccine, and 2,359,781 people have received their second dose.

Denmark started vaccinating against COVID-19 on 27 December 2020. Vaccination in Denmark is free of cost and voluntary. It is available to all residents of Denmark and those from abroad staying for more than 30 days in Denmark. Denmark has one of the highest levels of COVID-19 vaccination in the European Union as of the end of September 2021.

References

  1. "La stratégie vaccinale" (Press release). Ministère des Solidarités et de la Santé. 4 December 2020. Retrieved 30 January 2021.
  2. "Covid-19 : vaccination élargie à Porticcio et Bastia". France Bleu (in French). Radio France. 13 March 2021. Retrieved 30 April 2021.
  3. "Données relatives aux personnes vaccinées contre la Covid-19" (Press release). Santé publique France. Retrieved 30 January 2021.
  4. "Données relatives aux livraisons de vaccins contre la COVID-19" (Press release). Santé publique France. Retrieved 29 March 2021.
  5. "Covid-19 : AstraZeneca annonce de nouveaux retards de livraison de son vaccin à l'Union européenne". franceinfo (in French). France Télévisions. 13 March 2021. Retrieved 29 March 2021.
  6. "AstraZeneca : retards, effets secondaires… Pourquoi le vaccin anti-Covid crée la polémique de toutes parts". Le Figaro (in French). 14 March 2021. Retrieved 29 March 2021.